A trial like ALIC4E: Why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?

ERJ Open Research

Volumn 4, Issue 2, 2018, Pages

  Butler, Christopher C ^a   Coenen, Samuel ^b   Saville, Benjamin R ^c,d   Cook, Johanna ^a   van der Velden, Alike ^e   Homes, Jane ^a   de Jong, Menno ^f   Little, Paul ^g   Goossens, Herman ^h   Beutels, Philippe ^b   Ieven, Margareta ^b   Francis, Nick ⁱ   Moons, Pieter ^h   Bongard, Emily ^a   Verheij, Theo ^e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c LLC   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h ANTWERP UNIVERSITY HOSPITAL   (Belgium)

ⁱ CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; OSELTAMIVIR;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; FLU LIKE SYNDROME; HEALTH CARE UTILIZATION; HUMAN; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 85068476469     PISSN: None     EISSN: 23120541     Source Type: Journal    
DOI: 10.1183/23120541.00046-2018     Document Type: Article

References (7)

1. Dobson J, Whitley RJ, Pocock S, et al. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 2015; 385: 1729–1737.
2. Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014; 4: CD008965.
3. Krumholz HM. Neuraminidase inhibitors for influenza. BMJ 2014; 348: g2548.
4. Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013; 347: f5061.
5. Berry SM, Connor JT, Lewis RJ. The platform trial: an efficient strategy for evaluating multiple treatments. JAMA 2015; 313: 1619–1620.
6. Saville BR, Berry SM. Efficiencies of platform clinical trials: a vision of the future. Clin Trials 2016; 13: 358–366.
7. Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009; 62: 464–475.